Literature DB >> 22720779

Cognitive impairment in neuro-Behcet's disease and multiple sclerosis: a comparative study.

Tuncay Gündüz1, Özgür Emir, Murat Kürtüncü, Melike Mutlu, Ayfer Tumaç, Sükriye Akca, Oğuzhan Coban, Sara Bahar, Öget Öktem-Tanör, Erdem Tüzün, Mefkure Eraksoy, Hakan Gürvit, Gulsen Akman-Demir.   

Abstract

Both multiple sclerosis (MS) and neuro-Behcet's disease (NBD) can cause a cognitive dysfunction mainly involving the executive functions. We conducted this study to clarify the probable differential cognitive/behavioral profiles of MS and NBD. Twenty consecutive cases with parenchymal NBD (13 male, seven female), and 20 cases with MS (five male, 15 female) were evaluated. Both groups had a thorough neurological examination; an evaluation for Expanded Disability Status Scale (EDSS), Multiple Sclerosis Functional Composite (MSFC), and Beck's Depression Scale; and a detailed neuropsychological evaluation masked to the diagnosis. Among the two groups, male/female ratio differed significantly while other demographic and clinical features were not different. In California Verbal Learning Test, both short- and long-term delayed recall and cued recognition were worse in neuro-Behcet's cases. They had impaired semantic clustering and increased false positives. Stroop Test was also more impaired in neuro-Behcet's cases. They needed significantly more trials to complete the first category of the Wisconsin Card Sorting Test and had a poorer total Frontal Behavioral Inventory Score. Our results suggest that neuro-Behcet's patients have a more severe "frontal"-executive dysfunction than MS patients.

Entities:  

Mesh:

Year:  2012        PMID: 22720779     DOI: 10.3109/00207454.2012.704454

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  6 in total

Review 1.  Interleukin 6 and cognitive dysfunction.

Authors:  Isabel Trapero; Omar Cauli
Journal:  Metab Brain Dis       Date:  2014-04-30       Impact factor: 3.584

Review 2.  Behçet syndrome: a contemporary view.

Authors:  Hasan Yazici; Emire Seyahi; Gulen Hatemi; Yusuf Yazici
Journal:  Nat Rev Rheumatol       Date:  2018-01-03       Impact factor: 20.543

Review 3.  Outcome measures used in clinical trials for Behçet syndrome: a systematic review.

Authors:  Gulen Hatemi; Peter A Merkel; Vedat Hamuryudan; Maarten Boers; Haner Direskeneli; Sibel Z Aydin; Hasan Yazici
Journal:  J Rheumatol       Date:  2014-02-01       Impact factor: 4.666

Review 4.  Behçet's Syndrome and Nervous System Involvement.

Authors:  Uğur Uygunoğlu; Aksel Siva
Journal:  Curr Neurol Neurosci Rep       Date:  2018-05-23       Impact factor: 5.081

5.  Comparison of Cognitive Parameters Between Bilateral and Unilateral Hippocampal Sclerosis.

Authors:  Ebru Nur Vanli Yavuz; Başar Bilgiç; Zeliha Matur; Nerses Bebek; Candan Gürses; Ayşen Gökyiğit; Öget Öktem; Betül Baykan
Journal:  Noro Psikiyatr Ars       Date:  2016-03-28       Impact factor: 1.339

6.  Kleptomania in patients with neuro-Behçet's disease.

Authors:  Erkingül Shugaiv; Aslı Kıyat-Atamer; Erdem Tüzün; Murat Kürtüncü; Işın Baral-Kulaksızoğlu; Gülşen Akman Demir
Journal:  Med Princ Pract       Date:  2013-07-30       Impact factor: 1.927

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.